Editorial
 BAN ON FDC DRUGS   
 Wednesday, September 19, 2018 
 In a decisive action to weed out irrational, unscientific and hazardous drugs from the country’s pharmaceutical market, the Union Health Ministry has banned the controversial 328 Fixed Dose Combination drugs with immediate effect in the country. 
  Past Editorial...  
TODAY'S NEWS
15:00  [IST]St. Jude, Tessa collaborate to advance cellular immunotherapy treatments for childhood cancer
14:00  [IST]EMA committee recommends approval of Ipsen's Cabometyx tablets for previously treated HCC
13:30  [IST]EMA committee recommends approval of Biocon & Mylan's biosimilar Neulasta
13:20  [IST]Dynamic Bio-Medical introduces global radiography technology customized for Indian conditions
13:10  [IST]Kaisha Lifesciences new venture to introduce most advanced pharma products
13:00  [IST]IQVIA expands alliance to build clinical solution for life sciences on Salesforce Health Cloud
more news >>
TOP NEWS
08:00  [IST]Leading 15 international pharma cos register single digit sales & profit growth in first half of 2018; R&D spending up by 6.8%
08:00  [IST]Only 400 fertility clinics enrolled in National Registry of ART; experts pitch for stern steps to debunk false claims
08:00  [IST]Health ministry to create Registry of High Risk Medical Devices to study medical device associated adverse events
08:00  [IST]KIA's advanced temperature controlled pharma cargo centre enables convenience & connectivity for south Indian drug exporters
08:00  [IST]AICDF opposes e-pharmacy draft, seeks adoption of e-pharmacy at par with Western countries
08:00  [IST]Govt gets ready to amend rules to hold manufacturers accountable for faulty medical devices
more news >>
YESTERDAY'S NEWS
18:00  [IST]Sosei, Allergan voluntarily suspend clinical development of HTL0018318
17:00  [IST]NIH awards US$ 7.5 mn for international research programme to prevent & treat HIV infection in poor countries
16:00  [IST]Canon Medical System partners with ACTG to provide precision cancer medicine service in Japan
15:00  [IST]Amicus to pay US$ 100 mn to buy 10 gene therapy programmes in neurologic lysosomal storage disorders
14:00  [IST]EU grants marketing approval for Mylan & Fujifilm Kyowa Kirin Biologics' Hulio
13:00  [IST]Pfizer's 20vPnC candidate, PF-06482077 gets Breakthrough Therapy designation from US FDA
more news >>
INTERVIEW  
IT and AI impacting standards of Indian healthcare
Dilip_Jose.jpgDilip Jose, managing director & chief executing officer, Manipal Health Enterprises Pvt Ltd
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the central govt's decision to replace MCI with National Medical Commission boost the medical education scenario in the country?
  
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
CPhI-WW-Banners-150X60-120618-anim-v2
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |